Table 1 Baseline characteristics
Conventional group (n = 52) | Low-dose group (n = 55) | t-value/χ2 | P-value | |
|---|---|---|---|---|
Age | 63.46 ± 9.729 | 64.47 ± 11.883 | -0.480 | 0.632 |
Male/Female | 24/28 | 23/32 | 0.204 | 0.652 |
BMI (kg/m2) | 22.71 ± 2.403 | 22.59 ± 2.228 | 0.259 | 0.796 |
Heart rate (beats/minute) | 79.36 ± 13.049 | 78.02 ± 13.841 | 0.493 | 0.623 |
Coronary dominance | 0.485 | |||
Right-sided | 50 | 52 | ||
Left-sided | 1 | 3 | ||
Codominant | 1 | 0 | ||
CAD-RADS score | 0.184 | |||
0 | 18 | 15 | ||
1 | 9 | 3 | ||
2 | 9 | 18 | ||
3 | 10 | 11 | ||
4 A | 4 | 7 | ||
4B | 2 | 1 | ||
Cardiovascular risk factors | 0.422 | |||
Hypertension, n | 21 | 25 | ||
Diabetes mellitus, n | 8 | 8 | ||
Hyperlipidemia, n | 8 | 4 | ||
hepatic adipose infiltration, n | 5 | 2 |